Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Novo Nordisk (NVO) stock skidded Monday on reports a Food and Drug Administration inspection turned up "objectionable conditions" at a facility charged with making diabetes and weight-loss drugs.